NK-631 (peplomycin sulfate)

Known as: NK 631, NK-631, NK631 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1980
1980
A new bleomycin derivative NK631 was administered in five cases of advanced recurrent oral carcinoma. The visible improvement of… (More)
Is this relevant?
1979
1979
1979
NK 631, a new derivative of bleomycin, was clinically used in 14 cases of malignant tumors of skin. The results obtained were… (More)
Is this relevant?
1979
1979
Eight cases of malignant tumors of the head and neck were treated with NK 631 on a dosage schedule of 10 mg at a time 3 times… (More)
Is this relevant?
1978
1978
1. Organ distribution of pepleomycin (NK631) in mice and rats was studied. NK631 was found at higher levels than bleomycin (BLM… (More)
Is this relevant?
1978
1978
Studies on subactute toxicity and its recovery of pepleomycin sulfate (NK631) were carried out in both sexes of rats. NK 631 was… (More)
Is this relevant?
1978
1978
Subacute toxicity and its recovery of pepleomycin sulfate was studied in both sexes of beagle dogs. At dose levels of 2.4, 1.2… (More)
Is this relevant?